Roden awarded Vanderbilt’s Earl Sutherland Prize for Achievement in Research
Dr. Roden, Professor of Medicine, Pharmacology and Biomedical Informatics and Senior Vice President for Personalized Medicine, was awarded Vanderbilt’s most prestigious faculty honor for achievement in research.
Genetic analysis of people with African ancestry reveals lung cancer susceptibilities
A study led by researchers from Vanderbilt University Medical Center, including Department of Medicine Drs. Melinda Aldrich, Jacklyn Hellwege and Eric Gamazon has discovered genetic susceptibilities that may shed light on why people of African ancestry are disproportionately affected by lung cancer.
Clues offer hope for treating GI tract disorders
Michelle Southard-Smith, PhD, and colleagues, recently published a paper that details how single cell sequencing was used to identify how Sox10 mutations shift enteric neuron types by altering neuronal trajectories in early development of enteric nervous system development.
Large-scale study uncovers 57 genetic hotspots into stuttering origins
The largest genetic analysis of stuttering has demonstrated a clear genetic basis for the speech disorder, highlighting neurological pathways of risk. The study, published last week in the journal Nature Genetics by Dr. Piper Below (Genetic Medicine and Clinical Pharmacology) and colleagues, used data representing more than 1 million individuals who had their DNA analyzed by the company 23andMe Inc.
Multidisciplinary study develops tools for new ‘genomics of interorgan communication’
In a study that brings together genetics, gene expression and blood biomarkers, investigators have built a framework for exploring multiorgan cross talk in human health and disease.
Medicine faculty receive Komen leadership grants
Susan G. Komen has awarded $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing breast cancer. The grant recipients include Department of Medicine faculty Drs. Tuya Pal (Genetic Medicine and Clinical Pharmacology) and Ben Ho Park (Hematology and Oncology).
Study: Low blood cell counts drive cancer in explosive blood disorder
An analysis of genetic sequencing data from more than 34,000 people over a 17-year period by researchers at VUMC, including by Alex Bick, MD, PhD (Genetic Medicine), has found that persistent cytopenia appears to be a critical step in the progression of CHIP to blood cancer.
Tiny zebrafish aid discovery of rare, fatal genetic disease
In a study recently published in JCI Insight by Ela Knapik, PhD (Genetic Medicine) and colleagues, used zebrafish to study what happens in human cells when the transport protein expressed by SEC24C is lacking.